Total Payments
$38,083
2024 Payments
$49.41
Companies
13
Transactions
148
Medicare Patients
1,124
Medicare Billing
$114,661
Payment Breakdown by Category
Consulting$32,280 (84.8%)
Food & Beverage$2,045 (5.4%)
Other$1,790 (4.7%)
Research$1,003 (2.6%)
Travel$820.37 (2.2%)
Education$144.45 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,280 | 11 | 84.8% |
| Food and Beverage | $2,045 | 117 | 5.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,790 | 2 | 4.7% |
| Unspecified | $1,003 | 9 | 2.6% |
| Travel and Lodging | $820.37 | 4 | 2.2% |
| Education | $144.45 | 5 | 0.4% |
Payments by Type
General
$37,080
139 transactions
Research
$1,003
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $30,391 | 36 | $0 (2024) |
| Gilead Sciences, Inc. | $4,644 | 19 | $0 (2021) |
| Janssen Products, LP | $1,986 | 4 | $0 (2021) |
| Janssen Biotech, Inc. | $426.39 | 48 | $0 (2023) |
| Merck Sharp & Dohme LLC | $181.02 | 14 | $0 (2022) |
| Melinta Therapeutics, LLC | $138.21 | 10 | $0 (2023) |
| COMSORT, Inc | $100.00 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $50.82 | 6 | $0 (2019) |
| AbbVie Inc. | $50.55 | 3 | $0 (2021) |
| Insmed, Inc. | $47.02 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.41 | 3 | ViiV Healthcare Company ($34.49) |
| 2023 | $84.98 | 5 | ViiV Healthcare Company ($27.88) |
| 2022 | $3,960 | 6 | ViiV Healthcare Company ($3,900) |
| 2021 | $9,170 | 25 | ViiV Healthcare Company ($6,228) |
| 2020 | $3,816 | 10 | ViiV Healthcare Company ($3,697) |
| 2019 | $4,331 | 41 | ViiV Healthcare Company ($3,880) |
| 2018 | $7,998 | 34 | ViiV Healthcare Company ($7,649) |
| 2017 | $8,673 | 24 | ViiV Healthcare Company ($4,974) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Respiratory | ||||||
| 10/05/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: HIV | ||||||
| 03/01/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: HIV | ||||||
| 12/06/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Infections and Infectious Diseases | ||||||
| 09/11/2023 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/01/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: HIV | ||||||
| 04/06/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: ANTIBIOTICS | ||||||
| 01/19/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: HIV | ||||||
| 12/12/2022 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 08/24/2022 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Vabomere | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: ANTIBIOTICS | ||||||
| 04/05/2022 | ViiV Healthcare Company | DOVATO (Drug) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: HIV | ||||||
| 03/21/2022 | Merck Sharp & Dohme LLC | ZINPLAVA (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/21/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/05/2022 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/17/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.48 | General |
| 11/03/2021 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Vabomere | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ANTIBIOTICS | ||||||
| 08/06/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/26/2021 | Melinta Therapeutics, LLC | Vabomere (Drug) | Education | In-kind items and services | $11.95 | General |
| Category: ANTIBIOTICS | ||||||
| 07/14/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 07/09/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/30/2021 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: HIV | ||||||
| 06/16/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/26/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $860.00 | General |
| 05/24/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/21/2021 | Janssen Biotech, Inc. | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Ph 3 HIV two year non inferiority compared to standard of care safety tolerability acceptability of long acting injectable regimen | ViiV Healthcare Company | $1,003 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 225 | 376 | $70,440 | $21,378 |
| 2022 | 5 | 320 | 624 | $116,185 | $36,754 |
| 2021 | 6 | 269 | 488 | $98,241 | $29,880 |
| 2020 | 6 | 310 | 488 | $99,407 | $26,649 |
Total Patients
1,124
Total Services
1,976
Medicare Billing
$114,661
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 130 | $18,460 | $7,830 | 42.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 50 | $13,450 | $4,956 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 104 | $21,410 | $4,934 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 53 | $13,312 | $3,087 | 23.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 28 | $3,539 | $307.32 | 8.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $268.95 | $263.57 | 98.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 72 | 252 | $35,784 | $13,632 | 38.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 82 | 91 | $24,479 | $9,331 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 86 | $23,016 | $5,641 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 107 | $21,870 | $5,506 | 25.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 57 | 88 | $11,036 | $2,645 | 24.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 167 | $23,714 | $9,235 | 38.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 129 | $37,064 | $9,154 | 24.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 54 | 56 | $15,064 | $5,859 | 38.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 100 | $21,043 | $4,980 | 23.7% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 17 | 18 | $900.00 | $368.59 | 41.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 18 | $456.00 | $283.49 | 62.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 142 | $38,565 | $7,931 | 20.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 47 | 121 | $17,182 | $6,845 | 39.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 47 | 54 | $14,526 | $5,823 | 40.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 133 | $27,817 | $5,388 | 19.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 17 | 18 | $838.06 | $350.58 | 41.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 19 | 20 | $478.90 | $311.76 | 65.1% |
About Dr. Harold Katner, MD
Dr. Harold Katner, MD is a Infectious Disease healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821173808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Katner, MD has received a total of $38,083 in payments from pharmaceutical and medical device companies, with $49.41 received in 2024. These payments were reported across 148 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($32,280).
As a Medicare-enrolled provider, Katner has provided services to 1,124 Medicare beneficiaries, totaling 1,976 services with total Medicare billing of $114,661. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Macon, GA
- Active Since 10/26/2006
- Last Updated 07/17/2014
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1821173808
Products in Payments
- DOVATO (Drug) $13,994
- SYMTUZA (Drug) $1,978
- TRIUMEQ (Drug) $198.92
- Symtuza (Drug) $173.91
- PREZCOBIX (Drug) $164.60
- ISENTRESS (Drug) $148.47
- TIVICAY (Drug) $116.36
- SIVEXTRO (Drug) $100.00
- Orbactiv (Drug) $55.31
- XARELTO (Drug) $50.82
- Arikayce (Drug) $47.02
- Kimyrsa (Drug) $45.80
- Vabomere (Drug) $37.10
- Mavyret (Drug) $23.01
- EGRIFTA (Drug) $18.89
- Fetroja (Drug) $18.32
- TROGARZO (Drug) $16.08
- MINOCIN IV (Drug) $14.59
- AVYCAZ (Drug) $14.05
- Viekira (Drug) $13.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Macon
Jeffrey Stephens, Md, MD
Infectious Disease — Payments: $473,811
Infectious Disease $473,811
Ritu Kumar, Md, MD
Infectious Disease — Payments: $2,199
Infectious Disease $2,199
Michael Stevens, Md, MD
Infectious Disease — Payments: $886.21
Infectious Disease $886.21
Farhan Siddiqui, Md, MD
Infectious Disease — Payments: $689.80
Infectious Disease $689.80
Craig Smith, Md, MD
Infectious Disease — Payments: $59.42
Infectious Disease $59.42